Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
17β-Hydroxysteroid dehydrogenases (17β-HSDs) are a family of enzymes that catalyze the interconversion between less active and more active forms of estrogens and androgens. They play a crucial role in regulating local and systemic steroid hormone levels, influencing endocrine function and hormone-dependent diseases. Different isozymes exhibit varying substrate specificities and tissue distributions, allowing for fine-tuned control of hormone action. Inhibitors or modulators targeting specific HSD isoforms are under investigation for therapeutic use against hormone-dependent diseases.
Inhibition or modulation of specific HSD17B isoforms to alter local and systemic steroid hormone levels.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 17β-Hydroxysteroid Dehydrogenase (HSD17B).